[KongchangAI]
Unverified90% confidenceTradeoffTime unknown

降LDL-C能力在同等剂量下属于强效他汀,但原研可定价格显著高于国产仿制瑞舒伐他汀,长期用药经济负担是主要权衡点

1
Sources
90%
Confidence
Long-term
Relevance
-
First Seen

Sources

Related Entities

Related Claims

Cite This Claim

Stable URI
https://kongchang.com/claim/776828
API
curl https://kongchang.com/api/v1/knowledge/claims/776828
MCP
get_claim(id=776828)